Delivery Order SPE2DB22D3501-SPE2DB25FTN17
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,882.24, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 20, 2024. The contract was not designated with a set-aside requirement....
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUZ23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,440.43, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. This award is not associated with a...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY9R1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a ceiling value of $5,876.94. The contract type is Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 30, 2025. The contract is not...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,706.61, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is March 25, 2025. The award was made on March 24, 2025, and there is no set-aside...
This federal contract award, with the ID SPE2DB22D2005|SPE2DB24FJMK5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,351.88, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of May 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award, SPE2DB20D7059|SPE2DB24FPTK1, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a ceiling value of $1,075.70 and an ultimate completion date of October 23, 2023. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract was not set...
This federal contract award, with the ID SPE2DB22D3301|SPE2DB24FY8ES, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, and has a ceiling value of $6,360.78. It is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is June 10, 2024. The contract is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,145.19 and an ultimate completion date of May 21, 2024. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,273.82, is for the delivery of Fluticasone Propionate HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,378.28, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...